Colfax Corporation found that 15 analysts now cover the stock using the stock symbol (CFX). Analysts agreed that the rating is "Buy." The range between the high target price and the low target price is between 66 and 43, and our average target price is calculated to be 56.47. The stock's previous closing price was 44.89, which indicates a potential upside of 25.8%. The 50-day moving average is now at 49.63 and the 200-day moving average is at 46.65. The company's market capitalization is $7.097 billion. You can visit the company website in the following way: https://www.colfaxcorp.com
Colfax Corporation is a globally diversified technology company. The company operates two divisions, manufacturing technology and medical technology. The manufacturing technology department formulates, develops, manufactures and supplies consumables and equipment, including cutting, joining and automatic welding products, as well as gas control equipment. It also provides welding consumables, including electrodes, cored wires and solid wires, as well as fluxes that use a range of special materials and other materials; and cutting consumables, such as electrodes, nozzles, shields, and tips. The division sells its products to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas and mining markets through independent distributors and directly under the ESAB brand. The medical technology department develops, manufactures and distributes medical device products used by orthopedic specialists, spine surgeons, primary care doctors, pain management specialists, physical therapists, podiatrists, chiropractors, sports coaches and other healthcare professionals, It is used to treat patients with musculoskeletal diseases from degenerative diseases, deformities, traumatic events and sports-related injuries. It provides rigid and flexible orthopedic braces, hot and cold therapy products, bone growth stimulators, vascular therapy systems and pressure suits, therapeutic shoes and inserts, electrical stimulators and physical therapy products for pain management; and a set of products for Reconstructed joint products for hips, knees, shoulders, elbows, feet, ankles and fingers. The division sells its products through independent distributors, such as healthcare professionals, consumer retail stores and pharmacies; as well as direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
You can now share this content on Stocktwits, just click on the logo below and add the code to the text to view.
The good news spread quickly (but only if you did it):
View all sustainability departments, PLCs and news »
View all funds, market insights and news »
You understand and agree that any content posted on this website does not constitute a recommendation that any particular securities, portfolio of securities, trading or investment strategies are suitable or suitable for any particular person. You further understand that neither the information provider nor its affiliates will provide you with personal advice on the nature, potential, desirability, value, or applicability of any specific stocks, shares, securities, portfolios, transactions, investment strategies or other matters. We publicly disclose that we and our contributors may have interests in the investments and/or service providers mentioned on this website, and we receive compensation from certain companies mentioned on this website.